Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2013

View Archived Issues

Scientists at Tangrun Pharmaceuticals synthesize new HCV protease inhibitors

Takara Bio files gene therapy IND with Korean agency

EMA recommends approval of Sanofi Pasteur pediatric vaccine

Ignyta enters collaboration with Leiden University Medical Center

Nanologica to develop nanotechnology drugs with Russian biotech company

Antisense Pharma revises development strategy for anticancer candidate

CBK-201352 shows potent trypanotoxic activity in vitro and in vivo

Arrhythmogenic right ventricular dysplasia model established in vitro

Merck KGaA patents new LPA2 receptor antagonists

Novel agents for tuberculosis and cancer disclosed by CSIR

Researchers at the University of California synthesize novel GABA(A) receptor modulators

Japanese group discloses new ERRalpha inverse agonists

Novel first-in-class therapies hold promise in phase I for acute allergic reactions

Royalty Pharma proposes to acquire Elan

Mitsubishi Tanabe Pharma seeks additional indication for Tenelia in Japan

Shionogi applies for approval of Predonine in Japan

Isis Pharmaceuticals begins phase II study of ISIS-CRPRx in atrial fibrillation

Psyadon enrolls first patients in phase III study of ecopipam in Lesch-Nyhan disease

Inviragen develops dual-purpose recombinant MVA biodefense vaccine

Lytix Biopharma begins new phase II trial of LTX-109 for impetigo

Amarin files sNDA for Vascepa

United Therapeutics plans first clinical study of Pluristem's PLX-PAD cells in PAH

FDA approves Osphena for the treatment of dyspareunia

Arbovax creates tetravalent dengue virus vaccine

Likely delay to FDA review of Zohydro ER

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...